Expanded knowledge of cell-free DNA biology: potential to broaden the clinical utility
2022

Expanded Knowledge of Cell-Free DNA Biology

publication Evidence: high

Author Information

Author(s): Che Huiwen, Stanley Kate, Jatsenko Tatjana, Thienpont Bernard, Vermeesch Joris Robert

Primary Institution: KU Leuven, Belgium

Hypothesis

Can the analysis of cell-free DNA (cfDNA) broaden its clinical utility in various medical fields?

Conclusion

The study highlights the potential of cfDNA analysis to revolutionize clinical practice by providing noninvasive biomarkers for disease detection and monitoring.

Supporting Evidence

  • cfDNA analysis has revolutionized clinical practice by providing noninvasive biomarkers.
  • cfDNA is derived primarily from apoptotic hematopoietic cells.
  • cfDNA profiling has been successfully used in prenatal screening and oncology.

Takeaway

Scientists are studying tiny pieces of DNA that float in our blood to help doctors find diseases without needing to do painful tests.

Methodology

This review summarizes biological characteristics of cfDNA and its clinical applications across various medical fields.

Limitations

The review does not provide specific experimental data or sample sizes, limiting the ability to draw definitive conclusions.

Digital Object Identifier (DOI)

10.20517/evcna.2022.21

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication